NCT04845516

Efficacy and Tolerance of Therapeutic Apheresis in Paediatric Neurology: a French Multicenter Study

Efficacy and Tolerance of Therapeutic Apheresis in Paediatric Neurology: a Retrospective French Multicenter Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 200 (actual)
• Sponsor: University Hospital, Montpellier · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

After developing in pediatric hematology and nephrology, therapeutic apheresis is increasingly used in pediatric neurology despite a sparse level of evidence. There are a few retrospective series with a small number of patients, concerning mainly autoimmune diseases (encephalitis, myasthenia gravis, polyradiculoneuritis). The objective of this work is to study therapeutic apheresis (including plasma exchange and immunoadsorption) among french neuropediatric tertiary centers and to prove that this treatment modality is effective and well tolerated in pediatric neurology diseases.

Detailed description

Multicenter medical data collection : * Montpellier * Toulouse * Bordeaux * Marseille * Nancy * Paris Kremlin Bicêtre * Paris Robert Debré * Paris Necker * Paris Trousseau * Lyon * Besançon * Rennes * Reims * Strasbourg * La Réunion * Nantes * Tours

Conditions

• Apheresis Related Complication

Interventions

Type	Name	Description
OTHER	Efficacy of apheresis	Efficacy of apheresis

Timeline

• Start date: 2021-02-15
• Primary completion: 2021-12-01
• Completion: 2021-12-31
• First posted: 2021-04-15
• Last updated: 2022-04-12

Locations

1 site across 1 country: France